No results for ‘’
Anthem Biosciences Ltd
₹769.10
(1.46%)
Tue, 26 May 2026, 01:00 am
Health Technology
Biotechnology
24.5KAnthem Biosciences Price to Sales Ratio (P/S)
| Particulars | 2021 | 2022 | 2023 |
|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 |
| Price to book ratio | 0 | 0 | 0 |
| Price to sales ratio | 0 | 0 | 0 |
| Price to cash flow ratio | 0 | 0 | 0 |
| Enterprise value | 0 | 0 | 0 |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 |
| Debt to equity ratio | 0.03 | 0.07 | 0.12 |
| Return on equity % | 0 | 24.89 | 20.04 |
Anthem Biosciences Ltd Price to Sales Ratio
The Anthem Biosciences Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate Anthem Biosciences Ltd's valuation, profitability, and overall financial performance. Tracking the Anthem Biosciences Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Anthem Biosciences Ltd (NSE: ANTHEM, BSE: 544449) is currently trading at ₹769.10, with a market capitalization of ₹438.28B. As a leading company in the Health technology sector and Biotechnology industry, monitoring the Anthem Biosciences Ltd Price to Sales Ratio is essential for fundamental analysis.
Anthem Biosciences Ltd Price to Sales Ratio Current Value
The current Anthem Biosciences Ltd Price to Sales Ratio stands at 0.
The Anthem Biosciences Ltd Price to Sales Ratio remains stable, indicating consistent financial performance.
Anthem Biosciences Ltd Price to Sales Ratio Historical Trend
The Anthem Biosciences Ltd Price to Sales Ratio has shown the following historical trend:
- 2023: 0
- 2022: 0
- 2021: 0
The decline in Anthem Biosciences Ltd Price to Sales Ratio indicates improving financial efficiency or better earnings growth.
What Anthem Biosciences Ltd Price to Sales Ratio Indicates for Investors
The Anthem Biosciences Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/S ratio helps evaluate valuation relative to company revenue.
Anthem Biosciences Ltd Price to Sales Ratio Analysis Summary
The Anthem Biosciences Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Anthem Biosciences Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Anthem Biosciences Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.